[1] 张丽,周晓玲,朱姣,等,肝癌介入治疗术后早期功能锻炼对并发症的影响.肝脏2016,21,8:707-709.
[2] 中国抗癌协会肝癌专业委员会.原发性肝癌的临床诊断与分期标准. 肝脏. 2004,9:67.
[3] 中国抗癌协会癌症康复与姑息治疗专业委员会,中国临床肿瘤学会抗肿瘤药物安全管理专家委员会. 肿瘤治疗相关呕吐防治指南(2014 版). 临床肿瘤学杂志,2014,19:263-266. .
[4] 卢先东,时国兵.肝动脉介入化疗栓塞术后甲胎蛋白的应答对进展期肝癌预后的影响. 肝脏.2018,23:689-692.
[5] Lin YY,Lee RC,Tseng HS,et al. Objective measurementof arterial flow before and after transcatheter arterial chemo-embolization: A feasibility study using quantitative color-coding analysis. Cardiovasc Inter Rad,2015,38:1494-1501.
[6] Li XH,Wang YF,Sun GM. Transcatheter arterial chemoem-bolization combined with microwave coagulation therapy and the perioperative care for patients with hepatocellural carci-noma. J Buon Off,2015,20:1037-1041.
[7] Wu H,Zhao W,Liu S,et al. Pure transcatheter arteri-alchemoembolization therapy for intrahepatic tumors causes ashrink in pulmonary metastases of hepatocellular carcinoma. Int J Cli Expl Med,2015,8:1035-1042.
[8] 徐霞,季卫军,陆跃美. 甲孕酮联合介入治疗中晚期肝癌. 肿瘤学杂志.2002.8:367.
[9] Ruiz-García V, Juan O, Pérez Hoyos S,et al. Megestrolacetate: a systematic review usefulness about the weight gainin neoplastic patients with cachexia.Med Clin(Brac),2002,119:166.
[10] 黄一新,张政,金锡樟,等. 阿司匹林对 CKD3 期患者肾功能影响的探讨. 中国中西医结合肾病杂志,2015,16:33-37.
[11] 黄爱军,等.吲哚美辛栓治疗原发性肝癌经肝动脉栓塞化疗术后发热和疼痛的临床研究.现代医学,2016,44:368-370. |
